View Older Stories View More Recent Stories

Apr 20, 2026 08:32AM Piper Sandler Reiterates Overweight Rating on BridgeBio Pharma (BBIO)

Apr 15, 2026 05:10PM Jefferies on BridgeBio Pharma (BBIO): expecting Attruby sales to beat consensus estimates

Apr 8, 2026 04:15PM RBC Capital Starts BridgeBio Pharma (BBIO) at Outperform

Apr 8, 2026 12:12PM Barclays Positive on BridgeBio Pharma (BBIO): 'We expect continued strength from Attruby launch'

Mar 31, 2026 06:41AM H.C. Wainwright Reiterates Buy Rating on BridgeBio Pharma (BBIO)

Mar 30, 2026 03:30PM BridgeBio's acoramidis reduces mortality risk in heart disease patients

Mar 30, 2026 01:30PM Jefferies on BridgeBio Pharma (BBIO): 'Net-net, $1B+ peak sales seems reasonable'

Mar 30, 2026 09:50AM William Blair: 'we view BridgeBio as a core smidcap biotech holding'

Mar 30, 2026 07:31AM BridgeBio submits drug application to FDA for rare muscle disease

Mar 18, 2026 03:35PM BridgeBio Pharma (BBIO) PT Raised to $106 at Mizuho

Mar 12, 2026 09:24AM Leerink Partners Reiterates Outperform Rating on BridgeBio Pharma (BBIO) after data presentation: "risk/reward skewed to the upside"

Mar 10, 2026 12:42PM Barclays Reiterates Overweight Rating on BridgeBio Pharma (BBIO) amid tafamidis IP trial update

Mar 10, 2026 06:34AM William Blair Starts BridgeBio Pharma (BBIO) at Outperform

Feb 24, 2026 05:16PM BridgeBio Pharma Inc. (BBIO) Misses Q4 EPS by 28c

Feb 20, 2026 11:34AM BridgeBio Pharma (BBIO) Gains Tied to Market Chatter

Feb 12, 2026 10:03AM BridgeBio Pharma (BBIO) PT Raised to $89 at Raymond James

Feb 12, 2026 07:56AM TD Cowen comments on BridgeBio Pharma following positive infigratinib data

Jan 30, 2026 11:42AM Barclays Starts BridgeBio Pharma (BBIO) at Overweight

Jan 21, 2026 04:14PM BridgeBio issues $632.5 million convertible notes due 2033

Jan 12, 2026 01:42PM TD Cowen Reiterates Buy Rating on BridgeBio Pharma (BBIO)

Jan 12, 2026 10:31AM BridgeBio reports $362.4 million in Attruby revenue for 2025

Jan 6, 2026 02:11AM Morgan Stanley Starts BridgeBio Pharma (BBIO) at Overweight

Dec 22, 2025 07:06AM Piper Sandler Highlights Top Picks in the Biopharma 2026 Preview Note

Dec 21, 2025 08:00PM Here's the list of top biotech stocks to own for 2026

Dec 11, 2025 12:58AM Bernstein SocGen Group Starts BridgeBio Pharma (BBIO) at Outperform

Nov 10, 2025 02:33AM BridgeBio's acoramidis shows mortality benefit in ATTR-CM variant patients

Oct 30, 2025 09:39AM BridgeBio Pharma (BBIO) PT Raised to at TD Cowen as 'Attruby Beats Expectations Again'

Oct 30, 2025 06:20AM BridgeBio Pharma (BBIO) PT Raised to $100 at Goldman Sachs

Oct 30, 2025 05:37AM BridgeBio Pharma (BBIO) PT Raised to $75 at Leerink Partners

Oct 29, 2025 04:13PM BridgeBio Pharma Inc. (BBIO) Misses Q3 EPS by 7c

Oct 28, 2025 06:41AM BridgeBio Pharma (BBIO) PT Raised to $80 at H.C. Wainwright

Oct 27, 2025 01:30PM BridgeBio Pharma (BBIO) PT Raised to $69 at Raymond James

Oct 27, 2025 10:22AM BridgeBio Pharma (BBIO) PT Raised to $68 at Leerink Partners

Oct 27, 2025 09:20AM BridgeBio Pharma (BBIO) PT Raised to $90 at Evercore ISI

Oct 24, 2025 08:29AM Piper Sandler: 'Biotech Has a Heartbeat: 17 Stocks to Own Through YE25'

Oct 17, 2025 08:32AM Truist Securities: 'Is Biotech Back?!'

Sep 30, 2025 08:01AM Piper Sandler Sees 'A Good Setup for BridgeBio Pharma (BBIO) Shares to Outperform'

Sep 23, 2025 08:48AM UBS Reiterates Buy Rating on BridgeBio Pharma (BBIO)

Sep 22, 2025 09:09AM UBS Reiterates Buy Rating on BridgeBio Pharma (BBIO), Cites Confidence in Attruby

Sep 15, 2025 07:32AM H.C. Wainwright Reiterates Buy Rating on BridgeBio Pharma (BBIO)

Sep 12, 2025 09:01AM BridgeBio Pharma (BBIO) PT Raised to $82 at UBS on ADH1 Optimism

Sep 11, 2025 08:55AM UBS Reiterates Buy Rating on BridgeBio Pharma (BBIO), Optimistic on Encaleret

Sep 10, 2025 02:38PM TD Cowen on BridgeBio Pharma (BBIO): 'We anticipate an approval in 2026 with peak sales approaching $1B'

Sep 10, 2025 10:26AM Truist Securities Reiterates Buy Rating on BridgeBio Pharma (BBIO)

Sep 10, 2025 10:00AM Jefferies Reiterates Buy Rating on BridgeBio Pharma (BBIO)

Sep 8, 2025 07:12AM H.C. Wainwright Reiterates Buy Rating on BridgeBio Pharma (BBIO)

Sep 3, 2025 06:59AM BridgeBio Pharma (BBIO) Added to JPMorgan Positive Catalyst Watch List

Sep 3, 2025 06:59AM BridgeBio Pharma (BBIO) PT Raised to $70 at JPMorgan

Sep 2, 2025 06:56AM BridgeBio Pharma (BBIO) PT Raised to $70 at H.C. Wainwright

Aug 6, 2025 01:51PM TD Cowen on BridgeBio Pharma (BBIO): 'Attruby Is a Winner'

View More Recent Stories View Older Stories